Risankizumab
Catalogue number:
HY-P99248-1mg
Supplier:
Size:
1 mg
Product is available in:
Applications:
COVID-19-immunoregulation
Target:
Interleukin Related
Alternative Names:
Risankizumab rzaa; BI 655066; ABBV-066
- Data sheet: View or download
- MSDS: View or download
- Protocol: View or download
Product Description:
Risankizumab (BI 655066) is a humanised IgG monoclonal antibody, targeting IL-23 p19 subunit (Kd 50 = 2 pM). Risankizumab can be used to research immunological and inflammatory disorders such as psoriasis vulgaris, psoriatic arthritis, generalized pustular psoriasis and erythrodermic psoriasis[1][2][3].